DNA Simple Net Worth Shark Tank Update 2025

Olivier Noel founded the business DNA Simple in 2015. He recognized an issue that needed to be resolved. To investigate illnesses and discover treatments, several researchers required DNA samples. However, obtaining enough samples for research was challenging. Olivier developed DNA Simple to address this issue. Saliva samples are taken by DNA Simple and provided to researchers.

Diseases are studied using the samples. Individuals receive $50 in exchange for their saliva donations. Helping researchers is made simple with DNA Simple. The business is requesting $100,000 for a 12.5% stake in the company. This concept pleased the Sharks on Shark Tank. Olivier did a good job pitching his idea. Will the entrepreneur get a deal on Shark Tank? Check out The DNA Simple update to find out!

DNA Simple Net Worth Shark Tank Update 2025

Olivier Noel asked for a $100k investment in exchange for 12.5% equity in his company. This meant he valued DNA Simple at $800,000. He made a deal with Mark Cuban for $200k in exchange for 15% of his company. This new deal valued his company at $1.33 million. After the show aired, DNA Simple saw a big increase in website traffic, sales, and social media exposure. With an estimated 10% yearly growth rate (typical business growth), the current net worth of DNA Simple is about $5.26 million.

The Shark Tank episode increased the popularity of DNA Simple. The business continued to expand despite the agreement with Mark Cuban. Simple noticed an increase in its donor base following its appearance on the show DNA. Following the broadcast of the program, the firm achieved its goal of 100,000 samples. DNA Simple has 130,000 samples by December 2017.

Canadian samples are now being accepted by DNA Simple. By 2018, it set a new target of one million donations. The business kept assisting researchers by supplying DNA samples. Today, DNA Simple is still operating. It benefits researchers in Canada and the United States. Donors are still registered on the company’s website. DNA Simple appeared in numerous high-profile magazines.

These included NPR BuzzFeed and The Boston Globe. Olivier Noel continues to lead the company. DNA Simple is now helping researchers find cures faster. The company is making a big impact on health and science.

In terms of a DNA Simple update, Yes DNA Simple did get a deal on Shark Tank. Olivier Noel entered the tank seeking $100,000 for 12.5% of his company. Mark Cuban liked the idea and made an offer. He offered $200,000 for 20% equity in the company. Olivier wanted to keep more equity in the company. He made a counteroffer asking for $200,000 for 15%. Mark Cuban agreed to this offer.

Olivier accepted the deal. The Sharks liked the idea and supported Olivier. However, after the show, the deal with Mark Cuban did not close. Even though the deal fell through DNA Simple still grew. The exposure on Shark Tank helped the company gain more donors. It became much more successful even without the deal closing.

Shark(s) name	Offer & Demand	Counteroffer	Accepted?
Sir Richard Branson	$100,000 for 25% equity	N/A	N/A
Lori Greiner	Out	N/A	N/A
Robert Herjavec	Out	N/A	N/A
Daymond John	Out	N/A	N/A
Mark Cuban	$200,000 for 20% equity	$200,000 for 15% equity	Yes

DNA Simple Shark Tank pitch

The Olivier Haiti is where Noel was raised. The 2010 earthquake prompted him to go to New York. He put a lot of effort into earning a life when he arrived in the United States. He took on several occupations to help pay for his education. He provided tutoring in a variety of areas, including Spanish, chemistry, maths, and biology. He sold clothing at American Eagle in addition to working at Fossil.

Olivier obtained his degree in biological science after putting in a lot of study time in college. His areas of interest were biology and chemistry. He founded DNA Simple using what he knew. Olivier observed that it was difficult for researchers to obtain enough DNA samples for their investigations. His goal was to simplify the procedure. He founded DNA Simple in order to gather human samples. Researchers would then receive these samples.

Olivier was aware that many wanted to support medical research but were unsure of how to proceed. His goal was to develop a mechanism that would make it simple and secure for people to give their DNA. Saliva samples would be paid for by DNA Simple and sent to researchers. This approach would speed up the search for remedies. Involving the public in significant research would also be facilitated.

Olivier had a lot of difficulties at the beginning. He had to persuade people to give their genetic material. He had to locate researchers who were interested in using these samples as well. He needed to gain the trust of both researchers and donors. However, Olivier made DNA Simple a success by working hard and being persistent.

Olivier Noel walked into the Shark Tank with a bold pitch. He started by saying that the world was at risk of new pandemics. He explained that DNA research was important for understanding and fighting these diseases. Olivier told the Sharks that DNA Simple would make genetic research faster. His company would help researchers find cures faster. DNA Simple collects DNA samples from people.

The samples are sent to researchers who study diseases. Olivier showed the Sharks the saliva collection kits. He explained how they worked. People can sign up online and answer a few questions. Then they are matched with a research study. Once matched people get a kit with a prepaid label. They spit into the tube and send it back. After sending the sample people get $50.

They can donate as many samples as they want. Olivier told the Sharks that DNA Simple had already made $77,500 in revenue. He said that the company had completed 500 matches. Each time a match is made DNA Simple earns $155 from the researchers. The company only spends $12.50 to make each collection kit and pays donors $50. The Sharks were impressed with how simple and effective the idea was. Olivier asked for $100,000 in exchange for 12.5% equity in the company.

Olivier was asked a lot of questions by the Sharks. Lori Greiner requested that folks submit more than one sample. Olivier clarified that individuals may only submit samples if they were paired with a study. Mark Cuban enquired as to how the business confirmed the data provided by donors. “The researchers determined what proof they needed,” Olivier added.

If they needed more details they would get in touch with the contributors. Daymond John was curious about how much each kit cost. According to Olivier the cost of making each kit was $12.50. The business pays the donor $50 and then turns a slight profit. Richard Branson enquired into the background of Olivier. He was born in Haiti Olivier clarified.

He told the Sharks how he worked hard to pay for his education and how he traveled to New York. He described how he obtained a degree in biological science while working in a variety of occupations. Olivier was questioned by the Sharks regarding the margin in every game. According to Olivier, the business turned a profit at every game. He clarified that the business made $155 from researchers but only paid $50 to donors.

Lori Greiner was curious about the samples’ suitability for study. Olivier reassured the Sharks that scientists had confirmed the samples. Olivier’s business and story impressed the Sharks. They all commended his idea and his diligence. They could see how DNA Simple may speed up the search for treatments.

The Sharks had different opinions about the business. Richard Branson was the first Shark to make an offer. He liked the idea and offered $100,000 for 25% equity. Mark Cuban also liked the idea. He offered $200,000 for 20% equity. Olivier asked if he could hear a few more offers before making a decision. Mark Cuban told Olivier he needed to make a decision right away.

He insisted that Olivier choose his deal. Olivier hesitated but then made a counteroffer. He asked Mark Cuban for $200,000 for 15% equity instead of 20%. Mark agreed to the new terms and the deal was made. Olivier accepted Mark’s offer. The Sharks praised Olivier for his idea and his work. They said he had a great business model and a lot of potential.

What Went Wrong With DNA Simple On Shark Tank?

The agreement did not pique the interest of every Shark. Daymond John didn’t offer anything. He claimed he couldn’t see how he could support the company. Lori Greiner thought the concept was good but she was worried about the donors’ confidence. Robert Herjavec believed the company was too new to make an offer. The difficulties in obtaining enough samples and maintaining donor interest worried the Sharks.

But Olivier was successful in landing a deal with Mark Cuban thanks to his compelling proposal. After the show, the agreement with Mark Cuban did not close but the business expanded nonetheless. Following the episode DNA Simple’s success and donor base increased significantly.

Product Availability

DNA Simple offers a simple and unique product. The product is a saliva collection kit. The kit is easy to use. Donors sign up on the company’s website and answer a few questions. Then they are matched with a research study. Once matched the company sends the donor a kit. The donor spits into the tube and sends it back. DNA Simple pays $50 for each sample that is returned.

The company charges researchers $155 for each match. The DNA Simple kits are not available in stores. They can only be ordered online through the company’s website. The company has expanded to Canada. Donors from the U.S. and Canada can now participate in the program. DNA Simple continues to help researchers find cures. The company works with many research groups and hospitals. It is helping to make a difference in the fight against diseases.

Conclusion

Shark Tank was significantly impacted by DNA Simple. Olivier Noel wowed the Sharks with his pitch. The business negotiated a contract with Mark Cuban. DNA Simple expanded rapidly following the show despite the deal not closing. It reached a wider audience and attracted more donors. Today, the business supports researchers in Canada and the United States. Olivier is still in charge of the company.

Researchers are finding medicines more quickly thanks to DNA Simple. The business is presently successful and still expanding. We’re interested to see what DNA Simple does next.